Obtusifoliol

Details

Top
Internal ID 9ab1e2d5-bb28-4968-b7fe-02c8ff2f34ee
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Ergostane steroids > Ergosterols and derivatives
IUPAC Name (3S,4S,5S,10S,13R,14R,17R)-4,10,13,14-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
SMILES (Canonical) CC1C2CCC3=C(C2(CCC1O)C)CCC4(C3(CCC4C(C)CCC(=C)C(C)C)C)C
SMILES (Isomeric) C[C@H]1[C@@H]2CCC3=C([C@]2(CC[C@@H]1O)C)CC[C@]4([C@]3(CC[C@@H]4[C@H](C)CCC(=C)C(C)C)C)C
InChI InChI=1S/C30H50O/c1-19(2)20(3)9-10-21(4)23-13-17-30(8)26-12-11-24-22(5)27(31)15-16-28(24,6)25(26)14-18-29(23,30)7/h19,21-24,27,31H,3,9-18H2,1-2,4-8H3/t21-,22+,23-,24+,27+,28+,29-,30+/m1/s1
InChI Key MMNYKQIDRZNIKT-VSADUBDNSA-N
Popularity 28 references in papers

Physical and Chemical Properties

Top
Molecular Formula C30H50O
Molecular Weight 426.70 g/mol
Exact Mass 426.386166214 g/mol
Topological Polar Surface Area (TPSA) 20.20 Ų
XlogP 9.00
Atomic LogP (AlogP) 8.34
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 5

Synonyms

Top
16910-32-0
UNII-3RH57E39ER
3RH57E39ER
4alpha,14alpha-Dimethyl-5alpha-ergosta-8,24(28)-dien-3beta-ol
(3S,4S,5S,10S,13R,14R,17R)-4,10,13,14-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
Ergosta-8,24(28)-dien-3-ol, 4,14-dimethyl-, (3.beta.,4.alpha.,5.alpha.)-
4alpha,14alpha-dimethyl-24-methylene-cholest-8-en-3beta-ol
4alpha,14alpha-Dimethyl-24-methylene-5alpha-cholesta-8-en-3beta-ol
5.alpha.-Ergosta-8,24(28)-dien-3.beta.-ol, 4.alpha.,14-dimethyl-
(3S,4S,5S,10S,13R,14R,17R)-4,10,13,14-Tetramethyl-17-((R)-6-methyl-5-methyleneheptan-2-yl)-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Obtusifoliol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9971 99.71%
Caco-2 + 0.6421 64.21%
Blood Brain Barrier + 0.5500 55.00%
Human oral bioavailability - 0.6143 61.43%
Subcellular localzation Lysosomes 0.4702 47.02%
OATP2B1 inhibitior - 0.7173 71.73%
OATP1B1 inhibitior + 0.8262 82.62%
OATP1B3 inhibitior + 0.8637 86.37%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7250 72.50%
BSEP inhibitior + 0.7198 71.98%
P-glycoprotein inhibitior - 0.5669 56.69%
P-glycoprotein substrate - 0.5690 56.90%
CYP3A4 substrate + 0.6462 64.62%
CYP2C9 substrate - 0.6499 64.99%
CYP2D6 substrate - 0.6843 68.43%
CYP3A4 inhibition - 0.8499 84.99%
CYP2C9 inhibition - 0.8492 84.92%
CYP2C19 inhibition - 0.7480 74.80%
CYP2D6 inhibition - 0.9460 94.60%
CYP1A2 inhibition - 0.9054 90.54%
CYP2C8 inhibition - 0.5596 55.96%
CYP inhibitory promiscuity - 0.6154 61.54%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9500 95.00%
Carcinogenicity (trinary) Non-required 0.6245 62.45%
Eye corrosion - 0.9884 98.84%
Eye irritation - 0.9165 91.65%
Skin irritation + 0.5935 59.35%
Skin corrosion - 0.9398 93.98%
Ames mutagenesis - 0.8178 81.78%
Human Ether-a-go-go-Related Gene inhibition - 0.5158 51.58%
Micronuclear - 0.9600 96.00%
Hepatotoxicity - 0.5519 55.19%
skin sensitisation + 0.5493 54.93%
Respiratory toxicity + 0.6556 65.56%
Reproductive toxicity + 0.9444 94.44%
Mitochondrial toxicity + 0.9375 93.75%
Nephrotoxicity - 0.7995 79.95%
Acute Oral Toxicity (c) III 0.8414 84.14%
Estrogen receptor binding + 0.7511 75.11%
Androgen receptor binding + 0.8009 80.09%
Thyroid receptor binding + 0.7075 70.75%
Glucocorticoid receptor binding + 0.8082 80.82%
Aromatase binding + 0.6147 61.47%
PPAR gamma + 0.5413 54.13%
Honey bee toxicity - 0.7285 72.85%
Biodegradation - 0.8250 82.50%
Crustacea aquatic toxicity - 0.6200 62.00%
Fish aquatic toxicity + 0.9947 99.47%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.04% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 97.58% 91.11%
CHEMBL253 P34972 Cannabinoid CB2 receptor 97.26% 97.25%
CHEMBL2581 P07339 Cathepsin D 94.49% 98.95%
CHEMBL221 P23219 Cyclooxygenase-1 93.70% 90.17%
CHEMBL233 P35372 Mu opioid receptor 90.18% 97.93%
CHEMBL3137262 O60341 LSD1/CoREST complex 89.79% 97.09%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 89.59% 89.05%
CHEMBL1994 P08235 Mineralocorticoid receptor 88.39% 100.00%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 85.79% 95.50%
CHEMBL325 Q13547 Histone deacetylase 1 84.97% 95.92%
CHEMBL2996 Q05655 Protein kinase C delta 83.23% 97.79%
CHEMBL1795139 Q8IU80 Transmembrane protease serine 6 82.87% 98.33%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 81.57% 92.62%
CHEMBL4394 Q9NYA1 Sphingosine kinase 1 81.14% 96.03%
CHEMBL4227 P25090 Lipoxin A4 receptor 81.04% 100.00%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 80.69% 90.71%
CHEMBL1871 P10275 Androgen Receptor 80.04% 96.43%
CHEMBL5608 Q16288 NT-3 growth factor receptor 80.02% 95.89%

Cross-Links

Top
PubChem 65252
NPASS NPC121744
LOTUS LTS0243203
wikiData Q104251263